ETNA-VTE Europe: Benefits and risks of venous thromboembolism treatment using edoxaban in the first 3 months.

Saved in:
Bibliographic Details
Title: ETNA-VTE Europe: Benefits and risks of venous thromboembolism treatment using edoxaban in the first 3 months.
Authors: Agnelli, Giancarlo1 (AUTHOR) giancarlo.agnelli@unipg.it, Hoffmann, Ulrich2 (AUTHOR) ulrich.hoffmann@med.uni-muenchen.de, Hainaut, Philippe3 (AUTHOR) philippe.hainaut@uclouvain.be, Gaine, Sean4 (AUTHOR) sgaine@mater.ie, Ay, Cihan5 (AUTHOR) cihan.ay@meduniwien.ac.at, Coppens, Michiel6 (AUTHOR) m.coppens@amc.nl, Schindewolf, Marc7 (AUTHOR) marc.schindewolf@insel.ch, Jimenez, David8 (AUTHOR), Brüggenjürgen, Bernd9 (AUTHOR) bernd.brueggenjuergen@charite.de, Levy, Pierre10 (AUTHOR) pierre.levy@dauphine.fr, Laeis, Petra11 (AUTHOR) petra.laeis@daiichi-sankyo.eu, Fronk, Eva-Maria11 (AUTHOR) eva-maria.fronk@daiichi-sankyo.eu, Zierhut, Wolfgang11 (AUTHOR) wolfgang.zierhut@daiichi-sankyo.eu, Malzer, Thomas11 (AUTHOR) thomas.malzer@daiichi-sankyo.eu, Manu, Marius Constantin11 (AUTHOR) marius.manu@daiichi-sankyo.eu, Reimitz, Paul-Egbert11 (AUTHOR) paul-egbert.reimitz@daiichi-sankyo.eu, Bramlage, Peter12 (AUTHOR) peter.bramlage@ippmed.de, Cohen, Alexander T.13 (AUTHOR) alexander.cohen@kcl.ac.uk
Source: Thrombosis Research. Dec2020, Vol. 196, p297-304. 8p.
Database: Academic Search Ultimate
Be the first to leave a comment!
You must be logged in first